What Happens Next? Value Assessment, Drug Pricing Policy, and the R&D Pipeline

Wednesday, June 8, 12 p.m. ET


Joshua Cohen

Deputy Director, Center for the Evaluation of Value and Risk in Health at Tufts Medical Center
Jeffrey Handwerker

Jeffrey L. Handwerker

Partner, Arnold & Porter
Anna Kaltenboeck

Anna Kaltenboeck

Senior Health Advisor, US Senate Committee on Finance


Noam Kirson

Noam Kirson

Managing Principal, Analysis Group

Webinar Recording